Skip to main content

Year: 2024

Great Pacific Gold Announces Commencement of Drilling at Kesar

VANCOUVER, British Columbia, Oct. 22, 2024 (GLOBE NEWSWIRE) — Great Pacific Gold Corp. (“Great Pacific Gold,” “GPAC,” or the “Company”) (TSXV: GPAC) (OTCQX: FSXLF) (Germany: V3H) is providing an update on one of its core projects, the Kesar Project (“Kesar” or the “Project”) located in the Eastern Highlands province of Papua New Guinea. The Company’s previously announced 5,000 meter drill program at the Anteruno target, the first drill target at Kesar, has commenced. HighlightsAnteruno represents the first of a number of targets contained on a 5km x 5km area in the south-east corner of the Kesar concession, near the border with K92 Mining’s Kainantu mine concessions In total, thirteen drill holes are planned to test the Anteruno target which consists of a vein-set/stockwork zone approximately 1,000m x 200m Holes...

Continue reading

Trump Media Announces Release of Truth+ Streaming on Android TV

Truth Social TV streaming app now available for at-home Android TV sets SARASOTA, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) — Trump Media & Technology Group (Nasdaq: DJT) (“TMTG” or the “Company”), operator of the social media platform Truth Social, announced today that it has successfully launched an app for Android TVs to access the Truth+ streaming platform. Now available in the Google Play Store for Android TVs, Truth+ offers TV programming focusing on news, entertainment, faith-based content, weather, documentaries, children’s content, and more, featuring both linear TV channels and Video on Demand (VOD). Previously released for iOS devices, Android devices, Apple TVs, and on the Web, Truth+ enhances the limited streaming option now available on the Truth Social platform by adding additional content...

Continue reading

AmpliTech Group’s AGTGSS Division Signs 5 Year Supplier Agreement With Fujitsu Spain For Private 5G Network Products

HAUPPAUGE, N.Y., Oct. 22, 2024 (GLOBE NEWSWIRE) — AmpliTech Group, Inc. (Nasdaq: AMPG, AMPGW), a designer, developer, and manufacturer of state-of-the-art signal processing components for satellite, Public and Private 5G, and other communications networks, including the design of complete 5G/6G systems and a global distributor of packages and lids for integrated circuits assembly, today announced the signing of a 5 Year Supplier Agreement to provide Fujitsu with a varied array of Private 5G Network products, including AmpliTech’s 5G ORAN radios, 5G Customer Premises Equipment (CPE), 5G CU/DU and Core Servers as well as other ancillary products required to set a Private 5G Network at the end user’s site. AGTGSS, a provider of advanced 5G telecommunications solutions, is pleased to announce the signing of this strategic 5-year supplier...

Continue reading

Autonomix Announces Reverse Stock Split

THE WOODLANDS, TX, Oct. 22, 2024 (GLOBE NEWSWIRE) — Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company focused on advancing precision nerve-targeted treatments, today announced that it filed an amendment to its amended and restated certificate of incorporation with the Secretary of State of the State of Delaware to effect a 1-for-20 reverse stock split of its common stock. The reverse stock split will take effect at 11:59 pm (Eastern Time) on October 24, 2024, and the Company’s common stock will open for trading on The Nasdaq Capital Market on October 25, 2024 on a post-split basis, under the existing ticker symbol “AMIX” but with a new CUSIP number 05330T 205. As a result of the reverse stock split, every 20 shares of the Company’s common stock issued and outstanding prior to the opening...

Continue reading

SeaStar Medical to Distribute QUELIMMUNE Directly to Hospital Customers

DENVER, Oct. 22, 2024 (GLOBE NEWSWIRE) — SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage medical device company developing proprietary solutions to reduce the consequences of hyperinflammation on vital organs, announces that it has assumed all responsibility for direct sales, marketing and distribution of QUELIMMUNE™ to hospital customers. QUELIMMUNE is SeaStar Medical’s therapeutic device approved for the treatment of pediatric acute kidney injury (AKI) due to sepsis or a septic-like condition. “The SeaStar Medical team is focused on a successful commercial rollout with this game-changing therapy, QUELIMMUNE, to treat severely ill children. We have the infrastructure and operational capabilities in place to market and ship QUELIMMUNE directly to hospital customers and are confident we can seamlessly...

Continue reading

NAPC Defense, Inc. (OTCPK: BLIS) issues Progress Report regarding Large Contract with Saudi Arabia

LARGO, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) — NAPC Defense, Inc., (OTCPK: BLIS) (“NAPC” or “the Company”) announces that representatives recently returned from an additional two weeks of meetings and CornerShot USA weapons systems demonstrations in Saudi Arabia. As previously announced, NAPC received a signed and stamped LOI from Saudi Arabia for an initial order of 37,000 units of the CornerShot, valued at (U.S.) $370 million. Management is pleased to report the following updates:During the most recent two-week trip in Saudi Arabia, NAPC representatives successfully demonstrated CornerShot at the Tabuk military installation in northern Saudi Arabia to four military groups.Two more demonstrations are scheduled in November for two special operations military groups in Saudi Arabia.The proposed final contract is expected...

Continue reading

NextNav Announces Date for Third Quarter 2024 Earnings Call

RESTON, Va., Oct. 22, 2024 (GLOBE NEWSWIRE) — NextNav (Nasdaq: NN), a leader in next generation positioning, navigation, timing (PNT) and 3D geolocation, today announced that it will release its financial results for the third quarter ended September 30, 2024 after the market closes on Wednesday November 13, 2024, and will host a conference call the same day at 5:00 PM ET to discuss its results. Registration for the conference call can be completed by visiting the following website prior to, or on the day of, the conference call: https://registrations.events/direct/Q4I6293675922. After registering, each participant will be provided with call details and a registrant ID. Reminders will also be sent to registered participants via email. Alternatively, the conference call will be available via a live webcast. To access the live webcast...

Continue reading

Power Electronics Market is Poised to Grow at CAGR of 5.6% by 2031 | SkyQuest Technology

Westford, USA, Oct. 22, 2024 (GLOBE NEWSWIRE) — Power Electronics Market size was valued at around 43.5 billion in 2022 and is expected to rise from USD 46.1 billion in 2023 to reach a value of USD 71.3 billion by 2031, at a CAGR of 5.6% over the forecast period (2024–2031). The power electronics market is one of the rapidly growing sectors in the global economy. However, its scope can go farther with a wider variety of electronic systems and components being designed to convert and regulate power with efficiency across diverse applications. It strives to develop novel power management solutions for end industries such as automotive, aerospace, energy, and healthcare. The increased requirement of fighting against climate change and thereby reducing carbon emissions has led to an increased demand for efficient energy solutions,...

Continue reading

Houston Natural Resources Reports Q3 2024 Financials Period Ending September 30, 2024

HOUSTON, Oct. 22, 2024 (GLOBE NEWSWIRE) — Houston Natural Resources Corp. (OTC: HNRC) (“the Company”) reported today Q3 2024 results, concluding on September 30, 2024, as compared to Q3 2023 ending on September 30, 2023. Key Highlights for Nine Months Results: Q3 2024 Ending September 30, 2024 vs Q3 2023 Ending September 30, 2023Total revenue was $13,094,326 for nine months in 2024, compared to $15,241,815 for nine months in 2023. Total earnings for nine months in 2024 amounted to $8,764,980, compared to $8,871,912 for nine months in 2023. Earnings per share (EPS) for nine months in 2024 was $0.02, compared to $0.02 for nine months in 2023.The company achieved a net asset value (NAV) of $0.20c per share in Q3 2024. Additionally, the company reported successful milestones including: Acquisition of Cunningham Energy, LLC:Achieved...

Continue reading

Catalyst Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 6, 2024

The Company will Host a Conference Call and Webcast on Thursday, November 7, 2024, at 8:30 AM ET CORAL GABLES, Fla., Oct. 22, 2024 (GLOBE NEWSWIRE) — Catalyst Pharmaceuticals, Inc. (“Catalyst” or “Company”) (Nasdaq: CPRX), a commercial-stage biopharmaceutical company focused on in-licensing, developing, and commercializing novel medicines for patients living with rare and difficult-to-treat diseases, today announced that it will release its third quarter 2024 financial results after the market close on Wednesday, November 6, 2024. Catalyst’s management team will host a conference call and webcast on Thursday, November 7, 2024, at 8:30 AM ET to discuss the Company’s financial results and provide a business update.Conference Call & Webcast Details   Date: November 7, 2024Time: 8:30...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.